The OPERA study, conducted by ADSCC, aims to evaluate the safety and efficacy of Extracorporeal Photopheresis (ECP) as a potential treatment for type 1 diabetes mellitus (T1DM).
ADSCC has developed a clinical trial for the treatment of Multiple Sclerosis (MS). The PHOMS Study is a randomized, controlled, open-label assessment, centered on the safety and efficacy of Extracorporeal Photopheresis (ECP) in treating MS.
Dedicated to advancing medical research, ADSCC takes a leading role in fostering innovation in healthcare.
Since inception in 2019, ADSCC has been a beacon of progress dedicated to pioneering advancements in stem cell research and healthcare solutions.
In addition to the myriad publications, ADSCC houses a comprehensive collection of abstracts encapsulating the wealth of knowledge generated by our researchers.
Mahdar Qutouf Street, Rowdhat, Abu Dhabi, UAE
Near Al Rawafed Pvt. School - Mhanna St -
Khalifa City - SE44 - Abu Dhabi, UAE
